Related Experiment Videos
Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions
J Alegre1, J Jufresa, R Segura
1Dept of Internal Medicine, Vall d'Hebron General Hospital, Barcelona, Spain. 18502jam@comb.es
Abstract:
The diagnostic accuracy of myeloperoxidase (MPO) in pleural fluid, for differentiating between complicated and noncomplicated parapneumonic pleural effusions (PPE) evaluated prospectively. Seventy patients aged >18 yrs with PPE (36 complicated and 34 noncomplicated) were studied after admission to a tertiary referral teaching hospital. MPO concentration was measured in plasma and pleural fluid using a double-antibody competitive radioimmunoassay. The concentrations of MPO in complicated and noncomplicated PPE were compared using a Mann-Whitney U-test and multiple logistic regression models were used to predict the odds that an effusion was complicated. MPO pleural-fluid concentrations were significantly higher in complicated than in noncomplicated PPE. After excluding purulent effusions, pleural-fluid MPO was the marker that best differentiated between the two types of PPE: the area under the receiver operating characteristic curve was 0.912, the sensitivity was 87.5% and the specificity was 85.1% at a cut-point limit of 3.000 microg x L(-1). The authors concluded that the concentration of pleural-fluid myeloperoxidase helps to differentiate between nonpurulent complicated and noncomplicated parapneumonic pleural effusions.
Insights
Myeloperoxidase (MPO) in pleural fluid effectively distinguishes complicated from noncomplicated parapneumonic pleural effusions (PPE). Elevated MPO levels in pleural fluid show high diagnostic accuracy for identifying complicated PPE.
Area of Science:
- Pulmonology
- Clinical Chemistry
- Diagnostic Medicine
Background:
- Parapneumonic pleural effusions (PPE) require accurate differentiation between complicated and noncomplicated types for appropriate management.
- Distinguishing complicated from noncomplicated PPE is crucial for timely intervention and improved patient outcomes.
- Existing diagnostic methods may have limitations in accurately differentiating PPE subtypes.
Purpose of the Study:
- To prospectively evaluate the diagnostic accuracy of myeloperoxidase (MPO) in pleural fluid for differentiating complicated from noncomplicated PPE.
- To assess the utility of pleural fluid MPO concentration as a biomarker for complicated PPE.
Main Methods:
- Prospective study of 70 adult patients with PPE (36 complicated, 34 noncomplicated).
- Myeloperoxidase (MPO) concentration measured in plasma and pleural fluid using radioimmunoassay.
- Statistical analysis included Mann-Whitney U-test and logistic regression to compare MPO levels and predict complicated effusions.
Main Results:
- Pleural fluid MPO concentrations were significantly higher in complicated PPE compared to noncomplicated PPE.
- After excluding purulent effusions, pleural fluid MPO demonstrated high accuracy in differentiation (AUC 0.912).
- At a cut-point of 3.000 microg/L, MPO achieved 87.5% sensitivity and 85.1% specificity for complicated PPE.
Conclusions:
- Pleural fluid myeloperoxidase concentration is a valuable biomarker for differentiating between complicated and noncomplicated parapneumonic pleural effusions.
- MPO measurement offers a sensitive and specific method to aid in the diagnosis of complicated PPE, particularly nonpurulent types.
- This finding supports the potential clinical utility of MPO in guiding the management of patients with parapneumonic pleural effusions.